Janux Therapeutics
Greg is a Professor of Chemistry, Molecular Biology, and Biochemistry and former Vice Chair at the University of California, Irvine.
Greg trained at Genentech, Harvard, and UC Berkeley before joining the faculty at UCI in 2000. His laboratory focuses on the interface between chemistry and biology, including the study of membrane proteins and bioelectronics. He is a leading expert in the application of phage diversity libraries and directed evolution to study receptor-ligand interactions.
His awards include the Beckman Foundation Young Investigator, election to Fellow of the American Association for the Advancement of Science, and an Ig Nobel Prize in Chemistry for leading the team that “partially unboiled the egg.” He has co-authored 90 publications, co-invented more than 10 patents, and presented 200 invited seminars.
This person is not in the org chart
This person is not in any offices
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.